BET-IN-14
BET-IN-14 is an orally active pan BET inhibitor (IC50: 5.35 nM) . BET-IN-14 has anti-cancer activity[1].
Product Specifications
CAS Number
[2243669-93-2]
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-in-14.html
Purity
99.07
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC=C(N2C(C3=CC(N(C4CCCC4)[C@H](C)C(N5C)=O)=C5C=C3)=NC(C(N6CCN(C)CC6)=O)=N2)C=C1
Molecular Formula
C30H37N7O2
Molecular Weight
527.66
References & Citations
[1]Damaneh MS, et al. A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction. Invest New Drugs. 2020 Jun;38 (3) :700-713.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC214799L3V 200 µL
Beta TRCP (BTRC) (NM_003939) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
